Introduction
Essential hypertension is characterized by an increase in peripheral vascular resistance, at a time when the cardiac output is normal. Potentially a number of factors might be responsible for maintaining this. First, there is little doubt that structural alterations in the small arteries playa major role. It is clear that, even in the fully dilated vasculature, the lumen diameter of the resistance vessels is reduced! and the relationship between vessel diameter and internal pressure means this is certainly haemodynamically crucial.s Second, the overall contractile tone of the vascular smooth muscle is important. This is controlled by several mechanisms including the intrinsic myogenic ability of vascular smooth muscle to contract against intraluminal pressure and vasoconstriction effected by circulating hormones, local autacoids and neurotransmitters released from sympathetic nerves innervating the vascular media .. The neuroeffector junction (Figure 1) is a pnmary site for the regulation of vascular tone; variation in the degree of sympathetic innervation, overflow of neurotransmitters and presynaptic regulatory mechanisms which modulate synaptic concentrations, or vascular smooth muscle sensitivity to endogenous transmitters will influence arterial tone considerably. In hypertension much attention has been focused on the possibility that abnormalities of sympathetic nervous activity might be responsible for the disease, and the purpose of this review is to examine the evidence for changes in autonomic function and activity at the vascular neuroeffector junction in genetic rat models of hypertension and in human essential hypertension which may be pathogenetic in the hypertensive process.
Vascular smooth muscle function
The function of vascular smooth muscle has been investigated in vitro using traditional ring preparations, cannulation and perfusion of whole vascular beds;' and, more recently, the myograph technique to study smaller haemodynamically important resistance arteries.s The response to directly applied exogenous agonists can be described in terms of the magnitude of the contraction and this can be defined as the responsiveness of the vasculature. The threshold concentration of an agonist required to elicit a contraction and that required to elicit a half-maximal response provide an index of the agonist sensitivity of the tissue. Thus, the sensitivity refers to how early the tissue starts to respond to an agent and the responsiveness refers to the magnitude of the contraction. Structural alterations in small arteries are known to increase the responsiveness of a tissue either as a result of an increase in the amount of smooth muscle in the tissue or a rearrangement of existing smooth muscle into a more efficient formation.' and are independent of the specific agonist used to challenge the tissue. However, changes in agonist sensitivity are more likely to reflect alterations in receptor number or affinity,5,6 or excitation--eontraction coupling.
Frequently, in the spontaneously hypertensive rat (SHR), which is a genetic model of hypertension, isolated small arteries have been reported to have an increased responsiveness to exogenously applied noradrenaline, and other agonists, when compared with normotensive control Wistar Kyoto (WKY) rats.? When the response is normalized for the smooth muscle media thickness the interstrain difference in the response of the smooth muscle is eliminated, suggesting that this can be ascribed to structural alterations.? The sensitivity of intact small mesenteric arteries from SHR and WKY rats to exogenous noradrenaline is similar,7-9 again suggesting that there is no apparent difference in the function of the vascular smooth muscle cell in hypertension. However, if neuronal amine uptake is blocked, which is the main mechanism for reducing the synaptic concentration of noradrenaline, the sensitivity of arteries from SHR is enhanced.7,l0-12 Also, if arteries are chemically denervated using 6-hydroxydopamine, which removes sympathetic nerves and amine uptake mechanisms, mesenteric resistance arteriesf and tail artery strips13--15 from SHR are more sensitive to noradrenaline. These data suggest that vascular smooth muscle sensitivity to sympathetic stimulation is enhanced in the hypertensive rat strain compared with normotensive WKY rats, but that increased neuronal amine uptake effectively compensates and normalizes the sensitivity in intact conditions. However, not all studies confirm these findings. In femoral small arteries, which have a sparse innervation and therefore little neuronal amine uptake.w sensitivity to noradrenaline is not differentw or decreased'? in SH compared with WKY rats, in the presence and absence of the neuronal amine uptake inhibitor cocaine. In larger caudal arteries, sensitivity to exogenous noradrenaline is the same in adult SH and WKY animals, whether in the presence or absence of cocaine,18-21 or decreased in the SHR in the presence and absence of cocaine.w In addition, sensitivity to methoxamine, which is not a substrate for neuronal amine uptake, is also similar in caudal arteries from adult SH and WKY rats. 18,19 The sensitivity to noradrenaline was enhanced in caudal arteries from SHR, but only in chronically hypertensive (52-week-old) rats. 20 Therefore, data from small femoral and conduit caudal arteries suggest that sensitivity to exogenous noradrenaline is either unaltered or decreased in the SHR and, in contrast to the small mesenteric arteries, neuronal amine uptake is relatively unimportant in influencing the vascular smooth muscle sensitivity in these vascular beds. With respect to the role of neuronal amine uptake, an important difference is apparent between intact caudal arteries 18,19,21 and caudal artery stripS.14,15
In addition, the available data suggest that alterations in arterial smooth muscle sensitivity in SHR are dependent upon the vascular bed studied (Table 1 ). In the mesenteric arcade, the sensitivity of vascular smooth muscle to noradrenaline is enhanced but this is only apparent if neuronal amine uptake is blocked. Receptor binding studies indicate an increased affinity of postjunctional o-adrenoceptors for noradr~naline in mesenteric arteries from SHR,22 and this may account for the increased vascular smooth muscle sensitivity to noradrenaline here. However, in both caudal and femoral arteries noradrenaline sensitivity is either reported to be unaltered or decreased in SHR and, consistent with these data, the affinity and den~ity of a-adrenocept~rs is reported to be unaltered 10SHR caudal arteries.P The pervading view is that in arterial beds with a dense innervation there is enhanced sensitivity to exogenous catecholamines, if neuronal amine uptake is removed, with increased post junctional o-adrenoceptor binding affinities. These abnormalities are not seen in less well innervated vessels.
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Neural mechanisms: genetic animal models of hypertension
Evidence for enhanced sympathetic activity
In addition to vascular smooth muscle sensitivity, arterial tone is influenced considerably by the overall release of neurotransmitters from autonomic nerves. Indeed, the sympathetic nervous sy~tem has long~een .implicated in the pathogenesis of hypertension 10 SHR. Early experiments provided evidence for an increased sympathetic nerve activity in SHR. 24.25 In renal nerves sympathetic activity was dramatically greater in SHR, compared with Wistar control rats and appeared to be associated with the develõ pment of hypertension.> Furthermore, in sixth generation normotensive back-cross rats genetically related to SHR, the level of sympathetic nerve activity significantly correlated with blood pressure. 27 Chemical sympathectomy can be achieved in no~al rats using guanethidine to destroy penpheral nerves,28.29 but when administered to adult SHR for a period of six weeks it had no significant effect upon blood pressure.w However, when SHR were treated from birth over a period of 29 weeks, guanethidine produced a dose-dependent delay in the onset, but still did to WKY rats in the presence (+) or absence (-) of neuronal amine uptake. A blank entry indicates that the parameter was not assessed. The data suggest that vascular smooth muscle sensitivity to noradrenaline is increased in the mesenteric bed from SHR, but this is only apparent if the influence of neuronal amine uptake is removed. In intact caudal and femoral arteries neuronal amine uptake has a minor influence on smooth muscle sensitivity, which may reflect the sparser innervation; in these arteries noradrenaline sensitivitv is unaltered or decreased in the SHR. not prevent hypertension.3D Fluorescence histochemistry indicated that sympathetic nerves were still present in the mesenteric vasculature from four weeks onwards and at 31 weeks of age there was no difference in the density of nerves between guanethidine-treated and untreated SHR,3D indicating a resistance to chemical sympathectomy in these genetically hypertensive rats.
Nerve growth factor
Nerve growth factor (NGF) is considered to be critical in the development of sympathetic innervation, since administration of antibodies to NGF produces almost total sympathectomy, degradation of sympathetic ganglia and irreversible decreases in the levels of noradrenalinesynthesizing enzymes in normal rats. 31-33 Levels of mRNA for NGF are frequently reported to correlate with the degree of sympathetic innervation,34-37suggesting a close association between the density of nerves and the presence of this trophic factor. Furthermore, the concentration of NGF in mesenteric arteries was significantly elevated in young, but not adult, SHR compared with WKY rats 38 and levels of mRNA for NGF are reported to be elevated in mesenteric and caudal arteries from young SHR. 39 Treatment of SHR with anti-NGF during the first week postnatally is reported to prevent.w but most often only attenuates the development of, hypertension. 41 -44 Certainly, anti-NGF treatment of neonatal SHR for the first 15 days after birth was ineffective in preventing its development.w However, the combination of guanethidine and anti-NGF is more effective in preventing hypertension in SHR, and blood pressure was dramatically reduced in treated SHR at 15 weeks of age compared with untreated SHR. 43 Similarly, treatment of neonatal SHR for one week after birth with anti-NGF, followed by guanethidine administration for a further three weeks, prevented the development of hypertension in rats up to 28 weeks of age. 45 At the same time histofluorescence studies indicated that mesenteric and caudal arteries were devoid of sympathetic nerves.ss
Vascular sympathetic innervation
In the peripheral vasculature there is a wealth of evidence for increased sympathetic innervation in the SHR. 46 The content of noradrenaline has been reported to be increased in mesenteric arteries from young and adult SHR,21, 47-52 which may occur from as early as two days of age. 53 However, these findings have not been confirmed in mesenteric arteries from adult SHR. 54 Fluorescence and morphometric studies provide evidence to suggest an increased density of adrenergic nerves in mesenteric arteries 55--57 from as early as ten days of age , 58, 59 In addition to adrenergic nerves, a greater density of neuropeptide Y containing fibres has been reported in mesenteric arteries from young and adult SHR,60 indicating that hyperinnervation in the SHR may not be limited to adrenergic neurones.
In larger caudal arteries from adult SHR noradrenaline content is elevated,» but these changes are only apparent from 80 days onwards rather than from the very early age observed for the mesenteric vasculature.si These data are supported by an increased noradrenergic nerve fluorescence and increased number of axon bundles in the SHR.21 However, in the caudal artery these findings are not unequivocal; noradrenaline contents are reported to be similar in adult (ten to 28 weeks) SHR and WKY rats 14,61,62 and, therefore, evidence for an increased innervation in caudal arteries is not conclusive. Overall scrutiny of the literature suggests that the density of autonomic nerve fibres in arteries which are critically important to the control of vascular resistance is increased in genetically hypertensionprone rats, but that these findings are not necessarily applicable to larger conduit blood vessels.
Enhanced sympathetic innervation and nerve activity is not only important in terms of an increased vasoconstrictor influence: sympathetic nerves are also thought to exert a strong trophic influence on vascular smooth muscle. For example, surgical sympathectomy results in a decrease in media cross-sectional area and total artery wall thickness in rabbit ear artery.63,64 Also, treatment of SHR with anti-NGF,45 but not with antihypertensive agents,65 prevents the hyperplastic changes that occur during the development of hypertension, and the vascular smooth muscle itself is thought to release trophic NGF. Certainly, cell culture techniques indicate that vascular smooth muscle influences sympathetic nerve fibre growth. 66, 67 On the basis of such evidence, it has been proposed that the development of hypertension in the SHR may result from a combination of enhanced innervation and hyperplastic changes in vascular smooth muscle, and the critical involvement of trophic factors released from both nerves and smooth muscle reinforcing a positive feedback 100p.46
Overflow of endogenous neurotransmitter
Thus far data have been presented to support the argument that autonomic innervation and post junctional o-adrenoceptor binding affinity are deranged in important vascular beds in hypertension-prone rats. The functional consequences of an increased sympathetic innervation in hypertension are certainly evident. Many investigators have examined the overflow of endogenous neurotransmitter in SHR arteries. The absolute release of noradrenaline (ng/g tissue) has been measured as an index of the overall sympathetic innervation of arteries. However, the fractional release of noradrenaline measured as the overflow per total tissue noradrenaline content provides an index of the exocytotic release of noradrenaline, because it takes into account any increased nerve density.
Tsuda and colleagues have reported a greater absolute overflow of endogenous noradrenaline in the perfused mesenteric vasculature of sevento 20-week-old SHR,68-72 but in slightly older rats (20-22 weeks) noradrenaline overflo~was found to be similar between the strams,68 possibly reflecting an age-related effect. Similar age-related findings have been reported by others in the mesenteric vasculature: endogenous noradrenaline overflow was elevated in young (seven-to nine-week-old) SHR, but an interstrain difference was no longer apparent in older (13-and 20-22-week-old) rats. 52,73 Studying only mature rats (13-16 weeks), Yamamoto and Cline 74 also found that absolute endogenous noradrenaline overflow was not elevated in the SHR mesenteric vasculature, except at the highest frequencies. However, these findings are not unequivocal because the overflow of tritiated noradrenaline is reported to be enhanced in mesenteric arteries from adult, as well as young, SHR. 75
Although the absolute overflow of endogenous noradrenaline is enhanced in the SHR over an age range of six to 28 weeks in caudal arteries, the fractional overflow of endogenous noradrenaline was only raised at 28 weeks of age. 62 These findings have been confirmed: the
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fractional overflow of tritiated noradrenaline was not abnormal in 12-18-week-old SHR,76 but fractional overflow of endogenous noradrenaline is enhanced in chronically hypertensive rats.?? In addition, t~e fractional overflow of endogenous noradrenahne was not elevated in perfused mesenteric vasculature from young (four-to sixweek-old) SHR, although no report of absolute noradrenaline overflow was made.te Therefore, these data suggest that the absolute overflow of noradrenaline is enhanced in mesenteric and caudal arteries from spontaneously hypertensive rats, probably reflecting a greater nerve density (Table 2 ). The increased transmitter overflo.w occurred predominantly in young rats, and this may reflect a pathogenetic mechanism in the SHR. However, the fractional overflow of noradrenaline which reflects exocytotic release of transmitter tends only to be enhanced in chronically hypertensive rats and therefore may be a consequence of the hypertensive process. The possible. contributi<:>D of presynaptic regulatory mechanisms to the increased noradrenaline overflow is discussed below.
Vasoconstrictor responses to nerve stimulation
Studies of the vasoconstrictor responses to intramural and periarterial nerve stimulation become more difficult to interpret in terms of presynaptic function because alterations in postjunctional function may confound the response: an increased response to nerve stimulation may simply reflect an enhanced postjunctional response. Therefore the post junctional response to exogenously applied noradrenaline must also be known so it can be compared with the response to endogenously released neurotransmitter.
In the perfused mesenteric bed the pressor response to periarterial nerve stimulation was greater in the SHR when endogenous noradrenaline release was also elevated,7O-73 suggesting that presynaptic abnormalities contribute to the enhanced response to nerve stimulation. The pressor response to nerve stimulation in the perfused SHR mesenteric arteries tends to be increased to a greater degree than the pressor response to exogenous noradrenaline,12,52,78,79 and although the trends are not confirmed statistically these data also suggest an alteration in presynaptic function. Furthermore, in isolated to WKY rats. Measurement of fractional. rather than absolute. noradrenaline overflow is indicated by *. These data suggest an increase in absolute noradrenaline in the mesenteric bed, particularly in young SHR. In chronically hypertensive rats, the fractional overflow of noradrenaline is also enhanced. possibly reflecting the desensitization of autoinhibitory IX2-adrenoceptors.
mesenteric arteries the maximum response to nerve stimulation, expressed as a percentage of that to exogenous noradrenaline, was significantly enhanced in mature SHR,80 and Tsuji et a/. 8I report that, whilst the response to exogenous noradrenaline did not differ between the strains in young rats, the response to nerve stimulation was enhanced, again reflecting presynaptic changes in hypertension. However, Muir and Wardle'" report that nerve-mediated responses and exogenous noradrenaline responses are similar in the mesenteric bed.
The sensitivity to electrical field stimulation has been determined in isolated segments of mesenteric arteries. In adult rats (12-16 weeks) sensitivity to electrical field stimulation was greater in SHR compared to WKY rats,9,82.83 whereas the sensitivity to exogenous noradrenaline was similar between the strains.? In addition, the sensitivity to electrical field stimulation increased dramatically with the development of hypertension in mesenteric arteries from SHR (five to 12 weeks) but not in normotensive control rats,80 probably reflecting a presynaptic alteration in the exocyotic or absolute release of neurotransmitter.
In the caudal artery, Cassis et aPI reported an enhanced pressor response to nerve stimulation, but no difference in the response to exogenous noradrenaline. Therefore, the increased neurogenic response was not due to postsynaptic abnormalities, and these data suggest that presynaptic changes account for enhanced nerve-mediated constriction. Certainly, histological evidence indicated an increased innervation in these arteries.s! Although the pressor response to nerve stimulation was increased in SHR caudal arteries, with no interstrain difference in the response to exogenous noradrenaline, overflow of tritiated noradrenaline was not abnormal suggesting a lack of presynaptic alteration.?s Using caudal artery strips, and thereby preventing increased postjunctional responsiveness resulting from vascular geometry, responses to nerve stimulation were reported to be similar in adult SHR and WKY.14 In agreement with this, the response to exogenous noradrenaline and to nerve stimulation were equally enhanced in the SHR, indicating that prejunctional differences did not contribute to increased nerve-mediated constriction.s! Again, these data suggest heterogeneity between vascular beds in this rat genetic model of hypertension. In mesenteric arteries, which are important in the control of peripheral resistance, the evidence indicates a presynaptic abnormality resulting in an increased vasoconstriction to sympathetic stimulation. However, in caudal arteries most of the data suggest that prejunctional alterations may be absent in SHR, and this is consistent with the lack of evidence for increased innervation reported in some studies. 14,61,62 Therefore, the evidence suggests that where the vascular bed is important for blood pressure regulation neural defects are apparent.
Neuronal amine uptake
Catecholamine uptake at the neuroeffector junction is potentially an important mechanism for the regulation of the synaptic noradrenaline concentrations. An impairment of neuronal amine uptake would serve to increase the net overflow of noradrenaline, ultimately resulting in an elevated vasoconstrictor influence. However, investigation of the sensitivity of small arteries to exogenous noradrenaline, in the presence and absence of functional neuronal amine uptake, has suggested that neuronal amine uptake activity is enhanced rather than impaired in mesenteric arteries from young and adult SHR.7,8 The apparent increased effectiveness of neuronal amine uptake may reflect an increased activity of the uptake pump, an increased number of uptake pumps, or simply an increased number of upta~e pumps associated with an increased nerve density in the SHR.21 If the greater disposition of exogenous noradrenaline reflected only the increased sympathetic innervation in the SHR, one would not expect to find a difference in the effect of neuronal amine uptake blockade on responses to endogenous noradrenaline released via sympathetic nerve stimulation. However, blockade of uptake does enhance the nerve-mediated response to endogenous noradrenaline to a greater extent in young SHR compared to WKy.12,81 When mesenteric arteries from young and adult SHR were compared, the effect of uptake blockade was only enhanced in young, but not adult, SHR.52,80 These data suggest that the increased disposition of exogenous noradrenaline in adult SHR may reflect only the increased innervation, whereas the increased disposition of noradrenaline in young SHR may reflect a genuine alteration in uptake activity.
An increased reuptake of noradrenaline would oppose, rather than exacerbate, an elevated peripheral vascular resistance in hypertension. Therefore, it has been suggested that an increased neuronal amine uptake activity may provide a Neuroeffector function in hypertension 79 compensatory mechanism to oppose an enhanced vascular smooth muscle sensitivity to noradrenaline observed in some beds. 8,l3 However data which indicate an enha~ced uptake acti~ity in young, adult and chromcally hypertensive rats but only an increased noradrenaline sensitivity in chronically hypertensive rats, would not support this view. 84 Therefore, rather than enhanced neuron~l uptake being a specific compensatory mechamsm to oppose a greater noradrenaline sensi~ivity, these data support the hypothesis that increased uptake activity mainly reflects an increased innervation, at least in adult rats.
The question remains as to whether the enhanced contribution of amine uptake is linked directly to hypertension, or whether it is a genetic difference in the SHR unrelated to the elevated blood pressure, and this has been addressed by studying h~bri~rats from SHRlWKY matings. 85 The contr~butlOn ?f neuronal amine uptake was not different 10 mesenteric arteries from SHRlWKY F2-generation hybrid rats in the highest. and lowest blo~d pressure quartiles, suggest109 that uptake activity is not strictly associa!e?~ith blood pressure.eo However, uptake activity 10 caudal arteries taken from SHR WKY Fl-generation hybrids, Fl-generation ba~k-crosS HR and Fl-generation back-cross WKY rats correlated well with blood pressure.e-The situation remains unresolved, but a comparison of the two studies would favour a direct association.
Presynaptic a-adrenoceptors
Presynaptic a 2 -adrenoceptors are known to exist on nerve terminal varicosities and reduce the overflow of endogenous neurotransmitter p.on a~onist activation.et-so A physiological role IS implicated because «-adrenoceptor antagonists enhance the overflow of noradrenaline and functionally .increa~e the vasoconstrictor response to nerve stlmulatlon,88,9l suggesting that a negative feedback mechanism is normally active during sympathetic stimulation which serves to reduce transmitter overflow. An impairment of the normal feedback inhibition of neurotransmitter release would result in an increase in the overflow and synaptic concentration of noradrenaline, and potentially the postjunctional response. Therefore, the observed increase in noradrenaline overflow in the SHR model of hypertension has prompted much investigation of the function of presynaptic a 2-adrenoceptors, to determine whether an impairment might be responsible for enhanced transmitter release commonly observed in SHR vasculature.
The majority of studies have reported no alteration in~-adrenoceptor function in mesenteric vasculature from SHR over a range of ages (five to 20 weeks), measuring the effect of~-adrenoceptor antagonists on the overflow of tritiated noradrenaline.s-endogenous noradrenaline'< or on the nerve-mediated vasoconstriction. 9,8o,83 In young SHR presynaptic a 2adrenoceptors are reported to be supersensitive;" however, this would serve to reduce transmitter overflow rather than augment sympathetic stimulation. In contrast, there are data to suggest that presynaptic o-adrenoceptor function is impaired in the perfused mesentery of young, but not adult, SHR compared with normotensive rats. 68, 73 In caudal arteries and portal veins from chronically hypertensive SHR (28 weeks) the function of o-adrenoceptors has been reported to be impaired whilst it is normal in younger rats,62,77,93 and it is suggested that the aadrenoceptors may become desensitized as a result of excessive sympathetic activity during the development of hypertension, Certainly, increases in synaptic noradrenaline availability resulting from long-term neuronal amine uptake Table 3 Presynaptic a-adrenoceptor function inhibition are known to be associated with down-regulation of a-adrenoceptors,94-96 and sympathetic overactivity may have the same consequence.
In general, the evidence does not support a role of impaired e-adrenoceptor function in young animals developing hypertension, or during the early established phase of hypertension (Table 3) . Therefore, it seems unlikely that an impairment of this presynaptic regulatory mechanism contributes to an increase in the absolute noradrenaline overflow reported in young and adult SHR. In chronically hypertensive rats, the increased fractional release of endogenous noradrenaline thought to be representative of increased exocytotic release of noradrenaline from nerve terminals may be associated with the apparent desensitization of presynaptic o-adrenoceptors.
Presynaptic p-adrenoceptors
In addition to autoinhibitory a2-adrenoceptors, facilitatory prejunctional f3-adrenoceptors have been identified which enhance the overflow of noradrenaline. 97,98 These are generally considered to be the 132-subtype,81,99 although 13l"adrenoceptors have also been identified presynaptically,100-102 Although the regulatory capacity of presynaptic f3-adrenoceptors appears to be considerably less than that of lX-adrenoceptors,I03-104 an increased activation of these receptors resulting in enhanced neurotransmitter release potentially may play a role in the pathogenesis of hypertension.
The endogenous agonist for presynaptic 13adrenoceptors is thought to be adrenaline rather than noradrenaline;89,101.104 certainly, adrenaline is 1OG-200 times more potent at l3-adrenoceptors compared with noradrenaline.wt-w Adrenaline may facilitate neurotransmission via its acute effects as a circulating hormone released from the adrenal medulla, as well as with a more sustained action as a sympathetic cotransmitter taken up into nerve terminals by neuronal uptake and released with noradrenaline. 107,108 Rand et a/. 109 reported that l3-adrenoceptor antagonists were only effective in reducing transmitter overflow when adrenaline was coreleased with noradrenaline, supporting a role for adrenaline rather than noradrenaline as the endogenous agonist. In addition, the l3-adrenoceptor antagonist propranolol was ineffective in reducing the overflow of endogenous noradrenaline in isolated rat mesenteric vasculature, indicating that noradrenaline is unlikely to be the endogenous agonist at prejunctional Bsadrenoceptors and t~at in vitro conditions may not favour adrenalme cotransmission.v Certainly, adrenaline was not detected in the perfusion effluent collected during the study.v' . Raised levels of circulating adrenahne have been reported in the SHR,uo-ll2 and this may play an important role i!1. the. pat~o genesis of hypertension. In addition, infusion into normotensive rats of relatively low doses of adrenaline, but not of noradrenaline, has resulted in a sustained elevation in blood pressure which can be blocked by l3-adrenoceptor antagonlsm.u-.u-Therefore concentrations of adrenaline that do not alter plasma levels are capable of inducing hypertension in otherwise normal rats. Conversely, if the adrenal medulla is removed in young SHR the development of hypertension is attenuated,115--1l7 but treatment with 13 2 -adrenoceptor agonists co~nters the antihypertensive effect of demedullatlOn. 11 5. l !6
Following adrenalectomy pressor responses m pithed SHR are impaired, compared with shamoperated SHR, but can be restored by acute adrenaline infusion.Uf In addition, responses to periarterial nerve stimulation in mesenteric
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vasculature are reduced in SHR in which the adrenal medullas have been removed although responses to exogenous noradrenalinã re unchanged; infusion of adrenaline restores the neurogenic vasoconstriction to that observed in the sham SHR.1l7 These data suggest that release of adrenaline from the adrenal medulla may play a critical role in the development of hypertension in SHR; removal of the adrenals attenuates hypertension and vasoconstrictor responses to sympathetic stimulation, yet this can~e overcome by infusion of l3adrenoceptor agomsts.
The function of l3-adrenoceptors at the neuroeffector junction has been investigated in isolated vascular preparations. Infusion of 132-adrenoceptor blockers reduced periarterial neurogenic vasoconstriction in the mesenteric vasculature from SH, but not WKY, rats 81 indicating. a greater contribution of facilitato'ry presynaptic l3-adrenoceptors in hypertensive rats. These data may reflect an increase in the release of adrenaline as a cotransmitter in hypertension, or an alteration in l3adrenoceptor function per se, but cannot distinguish between the two possibilities. However, application of l3-adrenoceptor agonists increased the pressor response to periarterial nerve stimulation8l.99,119 and the overflow of tritiated noradrenaline75,119 to a greater degree in mesenteric arteries from SH compared with WKY rats. These data suggest that presynaptic l3-adrenoceptors are supersensitive to agonist stimulation in arteries from genetically hypertensive rats, at least in the mesenteric vasculature. Therefore, increased levels of circulating adrenaline in combination with alter~d presynapti~l3-adrenoceptor function may contnbute to the mcreased transmitter overflow observed by young SHR.
Summary
In summary, in the spontaneously hypertensive rat there is evidence that indicates not only a centrally mediated increase in sympathetic outflow but also an increase in the peripheral sympathetic innervation of blood vessels. Sympathectomy in neonatal SHR can attenuate the development of hypertension, and an important factor may be a restriction of the trophic influence of nerves upon the vasculature. Sympathetic stimulation is associated with an enhanced overflow of noradrenaline, and subsequently greater vasoconstrictor influence; whilst impaired presynaptic azadrenoceptors do not appear to contribute to this during the development of hypertension, there is some evidence that presynaptic~-adrenoceptors are supersensitive and may facilitate noradrenaline overflow to a greater extent in SHR. In addition, an enhanced vascular smooth muscle sensitivity may exacerbate an increased sympathetic influence in some vascular beds important for pressure control, if conditions were such that neuronal amine uptake are saturated. Therefore, in this rat genetic model of hypertension presynaptic and postsynaptic abnormalities at the neuroeffector junction may well contribute to the production of increased peripheral vascular resistance.
Studies in human essential hypertension
Vascular smooth muscle function in essential hypertension Many in vivostudies have reported an increased pressor response to o-adrenoceptor agonists in patients with essential hypertension compared with normotensive subjects. l 20-123 Although an exaggerated responsiveness to infused noradrenaline and angiotensin II in the forearm of essential hypertensives is reported, the sensitivity to noradrenaline is unaltered. 124.125 In addition, the sensitivity to the e-adrenoceptor agonist phenylephrine was unaltered in hand veins of essential hypertensives.Pe Therefore it appears that a general enhancement of vascular responsiveness, based on structural alterations of the vascular wall, accounts for the increased responsiveness without any alteration in «-adrenoceptor function.
Studies on isolated vessels provide little evidence for an alteration in noradrenaline sensitivity in large temporal arteries.P? digital arteries 128 and vessels obtained during abdominal surgery129 from patients with essential hypertension. However, cystic artery strips from female but not male hypertensives demonstrated an increased sensitivity to noradrenaline.P? In isolated small arteries from patients with essential hypertension, although the responsiveness to exogenous noradrenaline, serotonin, angiotensin II, vasopressin and potassium was enhanced there was no dif-ference in the sensitivity of the vascular smooth muscle to these agonists.P! Even after blockade of neuronal amine uptake the sensitivity to noradrenaline remained similar between the groups.P! Therefore, in essential hypertension an alteration in noradrenaline sensitivity is not generally apparent in either large or small arteries, findings which are notably inconsistent with the SHR model of hypertension at least in some vascularbeds.
Recent studies have identified the presence of functional postjunctional a 2-adrenoceptors in isolated human resistance arteries.Pt in addition to a1-adrenoceptors, which elicit vasoconstriction in response to noradrenaline. 133 Although postjunctional a2-adrenoceptors have previously been proposed to respond predominantly to circulating catecholamines rather than neurally released noradrenaline.Ps-P> it is now apparent that in human subcutaneous arteries both postjunctional a1-and a2-adrenoceptors respond to neurally released endogenous noradrenaline. 136.137 
Sympathetic activity in essential hypertension
Although vascular smooth muscle sensitivity to noradrenaline is not abnormal in essential hypertension, forearm infusion of the adrenergic antagonist phentolamine greatly reduced vascular resistance in hypertensive patients, effectively normalizing the difference between hypertensives and controlsvand thereby suggesting that the increase in vascular resistance may result from increased sympathetic tone. Indeed, much attention has been focused towards a possible role of the sympathetic nervous system in the pathogenesis of hypertension. Patients with mild hypertension demonstrate an elevated cardiac output,138-140 rather than the increased peripheral vascular resistance characteristic of established hypertension, and this condition has been termed 'hyperkinetic borderline hypertension'. Autonomic blockade of the heart in these patients normalized cardiac output, and both an increased sympathetic tone and decreased parasympathetic tone were evident. 141,142 A reciprocal change in the sympathetic and parasympathetic output is thought to suggest that the abnormality originates in the central nervous system cardiovascular centre. 143 In the periphery, plasma catecholamine levels have been used as a relatively crude index of sympathetic nerve activity based on the observations that transmitter release is proportional to the nerve firing rate l 44 and that plasma noradrenaline concentrations correlate with the level of sympathetic stirnulation.ts> Under resting conditions, plasma noradrenaline concentration is derived almost entirely from peripheral nerves, with a negligible contribution from the adrenal medulla l46-148 and the central nervous system. [149] [150] [151] In essential hypertension, plasma noradrenaline concentration was found to be elevated by on average 55 pglml (mean control plasma noradrenaline 250 pglml) in 52 of 64 studies reviewed, but this was only statistically significant in 40% of studies.Ps The age of the patient group considerably influenced the likelihood of a significant increase in plasma noradrenaline; in studies of young hypertensives (less than 40 years) a significantly elevated pl~sm.a noradrenaline was consistently apparent,152 indicating that sympathetic overactivity may be more important in early hypertension. Certainly, in older patients plasma noradrenaline levels are not abnormal. 153.154 Plasma noradrenaline levels reflect not only the sympathetic release of noradrenaline but also its clearance, metabolism and reuptake.P> However clearance of noradrenaline was not abnormal in essential hypertensive patients with elevated plasma noradrenaline.153.156-158 Alternatively, in vivo studies suggest that neuronal reuptake of noradrenaline is .defective in .a subgroup of patients with essential hyperte.nslOn.~57 Infusion of desipramine, but not cortlso.l, significantly lengthened the plasma half-hfe of noradrenaline indicating that neuronal uptake, but not extraneuronal uptake, is a major determinant of the disappearance of noradrenaline from plasma. 159 In a proportion of patients with essential hypertension (25%) the initial phase~f noradrenaline half-life was prolonged, and this was associated with an increased noradrenaline spillover. This subgroup included young, m.ild hypertensives (50%), indicating that defective uptake is not likely to be consequence ?f long-standing hypertension. Similarly, Goldstein et al. 158 reported evidence for defective uptake in a subgroup of hypertensive patients (25%) associated with an increased noradrenaline spillover.
Therefore, in vivo data suggest that an impaired
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neuronal amine uptake may contribute to the elevated plasma noradrenaline in a subgroup of patients with essential hypertension, but these findings are inconsistent with assessment of neuronal amine uptake in isolated small arteries which indicate an enhanced uptake in patients with essential hypertension.i» A more direct index of sympathetic nerve activity h~s been measured using~icroneurography te.chmques l 60 w~ere nerve fascicles are impaled With tungsten microelectrodes allowing multifibre recordings of sympathetic burst incidence. Early experiments suggested that the incidence of sympathetic burst activity in skin and muscle nerve fascicles were not different between hypertensive (mean age >35 years) and normotensive subjects. 161 Subsequent studies have suggested that sympathetic activity correlated with blood pressure, in both hypertensive and normotensive subjects, and burst incidence was greater in the hypertensive patients.162.163 However, in both of these studies a significant correlation between nerve activity and age was also observed; unfortunately subject groups were poorly age-matched and it is possible that increased age may have accounted for the increased sympathetic activity in the hypertensives. Therefore, these data do not provide good evidence for increased sympathetic nerve activity in essential hypertension. However, in a group of young borderline hypertensives s~mpathetic nerve activity was elevated compared With age-matched controls.re-Similarly, Yamada et al. 165 reported that sympathetic nerve activity was elevated in hypertensive patients, and this was significant for three distinct age groups «30 years, 3D-50 years, >50 years). Therefore, these data provide direct evidence that sympathetic erve acti.vity is enhanced in essential hypertension and, in contrast to the plasma noradrenaline data,152 suggest that the increased activity is not strictly limited to young patients.
Peripheral sympathetic nerve function in essential hypertension
Neuronal amine uptake activity has previously been suggested as a putative index of peripheral sympathetic irmervation.n In isolated segments of human subcutaneous arteries, blockade of neuronal amine uptake produces a greater shift in noradrenaline sensitivity in vessels from hypertensive patients than from normotensive controls-u and, as hypothesized in the SHR, this increased uptake activity may reflect an increased peripheral sympathetic innervation. Furthermore, in subcutaneous arteries from normotensive offspring of essential hypertensives an increased uptake activity was apparent as the only functional abnormality observed;l66 this was interpreted as a possible indication of enhanced innervation in subjects predisposed to developing hypertension.
At present there is very little direct evidence of peripheral sympathetic nerve function in essential hypertension. Recently, a technique of electrical field stimulation has been applied to isolated human subcutaneous arteries in vitro. 136 Frequency-dependent vasoconstriction was elicited over a range of 1-25 Hz, with the higher frequencies of stimulation mimicking those recorded during transient bursts of sympathetic nerve activity.Is? Preliminary data indicate that the sensitivity to electrical field stimulation does not differ between hypertensive patients and age-matched controls (unpublished data), and therefore provides no evidence for an enhanced peripheral innervation in patients with essential hypertension. In view of the considerable evidence to suggest an increased peripheral vascular sympathetic innervation in the SHR, these data may reflect a major difference in the aetiology of hypertension in humans and the rat genetic model.
p-Adrenoceptors and essential hypertension
Adrenaline is thought to play a role in the pathogenesis of essential hypertension; certainly, plasma levels are elevated in hypertensive patients,l68 and review of the literature-S indicates that plasma adrenaline is significantly elevated in 48% of published studies. Infusion of adrenaline caused a sustained increase in blood pressure in normal humans long after the infusion had ceased and plasma concentrations had returned to normal,I68.169 indicating a potential role of adrenaline in the elevation of blood pressure. Since the adrenaline-induced rise in both plasma noradrenaline and blood pressure could be inhibited by propranolol, the mechanism was considered to be via presynaptic -adrenoceptors which facilitate transmitter over-flOW. 168 Forearm infusion of~-adrenoceptor agonists attenuated the response to exogenous noradrenaline, presumably via postjunctional -mediated vasodilation, but not to reflex sympathetic nerve activity triggered by the lower body negative pressure (LBNP) technique,17°indicating the presence of prejunctional facilitatory~-adrenoceptors in humans which augment sympathetic neurotransmission. Sustained effects of adrenaline are thought to arise from the uptake of adrenaline into synaptic vesicles and subsequent release as a cotransmitter 107,108 and this hypothesis was tested in humans by comparing the long-term effects of adrenaline and of isoprenaline which is not a substrate for neuronal uptake. Adrenaline, but not isoprenaline, caused a sustained increase in sympathetic vasoconstriction triggered by LBNp170 and this was attenuated by desipramine.t?' indicating a role for neuronal amine uptake in the process.
However, there is little evidence for alteration in presynaptic~-adrenoceptor function in human hypertension. The acute and sustained effects of adrenaline on noradrenaline overflow l68,I72 and vasoconstriction elicited by LBNp170,l71 were not abnormal in hypertensive patients. Therefore, although the levels of circulating adrenaline may be increased in essential hypertension which would facilitate neurotransmission, these data provide no evidence to suggest that presynaptic -adrenoceptor function per se is altered.
Conclusion
At the site of the neuroeffector junction in human essential hypertension, there does not appear to be any alteration in postjunctional vascular smooth muscle sensitivity to agonists or prejunctional~-adrenoceptor sensitivity to agonist stimulation, and the enhanced neuronal amine uptake apparent in isolated small arteries would attenuate rather than augment the vasoconstrictor influence. In addition, preliminary data provide no evidence for an alteration in the sympathetic innervation in small arteries. However, there is considerable evidence for an increased centrally mediated sympathetic outflow in essential hypertension and this would contribute to an elevated vascular tone. Recent studies associate an increased cerebral noradrenaline turnover with increased peripheral sympathetic activity in some hypertensive patients,173 suggesting that an abnormality in cerebral noradrenergic activity may underlie higher peripheral sympathetic output in essential hypertension. 
